Dexmedetomidine for Sedation During Pediatric Noninvasive Ventilation

References

1. 1.↵
   1. Venkatraman R,
   2. Hungerford JL,
   3. Hall MW,
   4. Moore-Clingenpeel M,
   5. Tobias JD

   . Dexmedetomidine for sedation during noninvasive ventilation in pediatric patients. Pediatr Crit Care Med 2017;18(9):831-837.

   OpenUrl
2. 2.↵
   1. Traube C,
   2. Silver G,
   3. Gerber LM,
   4. Kaur S,
   5. Mauer EA,
   6. Kerson A,
   7. et al

   . Delirium and mortality in critically ill children: epidemiology and outcomes of pediatric delirium. Crit Care Med 2017;45(5):891-898.

   OpenUrl
3. 3.↵
   1. Mody K,
   2. Kaur S,
   3. Mauer EA,
   4. Gerber LM,
   5. Greenwald BM,
   6. Silver G,
   7. et al

   . Benzodiazepines and development of delirium in critically ill children: estimating the causal effect. Crit Care Med 2018;46(9):1486-1491.

   OpenUrlPubMed
4. 4.↵
   1. Gee SW,
   2. Lin A,
   3. Tobias JD

   . Dexmedetomidine infusion to control agitation due to anticholinergic toxidromes in adolescents, a case series. J Pediatr Pharmacol Ther 2015;20(4):329-334.

   OpenUrlPubMed
5. 5.↵
   1. Tobias JD

   . Applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med 2007;8(2):115-131.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Devlin JW,
   2. Al-Qadheeb NS,
   3. Chi A,
   4. Roberts RJ,
   5. Qawi I,
   6. Garpestad E,
   7. Hill NS

   . Efficacy and safety of early dexmedetomidine during noninvasive ventilation for patients with acute respiratory failure: a randomized, double-blind, placebo-controlled pilot study. Chest 2014;145(6):1204-1212.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Aydogan MS,
   2. Korkmaz MF,
   3. Ozgül U,
   4. Erdogan MA,
   5. Yucel A,
   6. Karaman A,
   7. et al

   . Pain, fentanyl consumption, and delirium in adolescents after scoliosis surgery: dexmedetomidine vs midazolam. Paediatr Anaesth 2013;23(5):446-452.

   OpenUrlPubMed
8. 8.↵
   1. Grant MJC,
   2. Schneider JB,
   3. Asaro LA,
   4. Dodson BL,
   5. Hall BA,
   6. Simone SL,
   7. et al

   ; Randomized Evaluation of Sedation Titration for Respiratory Failure Study Investigators. Dexmedetomidine use in critically ill children with acute respiratory failure. Pediatr Crit Care Med 2016;17(12):1131-1141.

   OpenUrl
9. 9.↵
   1. Piastra M,
   2. Pizza A,
   3. Gaddi S,
   4. Luca E,
   5. Genovese O,
   6. Picconi E,
   7. et al

   . Dexmedetomidine is effective and safe during NIV in infants and young children with acute respiratory failure. BMC Pediatr 2018;18(1):282.

   OpenUrl
10. 10.↵
    1. Lam F,
    2. Bhutta AT,
    3. Tobias JD,
    4. Gossett JM,
    5. Morales L,
    6. Gupta P

    . Hemodynamic effects of dexmedetomidine in critically ill neonates and infants with heart disease. Pediatr Cardiol 2012;33(7):1069-1077.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Carroll C,
    2. Krieger D,
    3. Campbell M,
    4. Fisher DG,
    5. Comeau LL,
    6. Zucker A

    . Use of dexmedetomidine for sedation of children hospitalized in the intensive care unit. J Hosp Med 2008;3(2):142-147.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Shutes BL,
    2. Gee SW,
    3. Sargel CL,
    4. Fink KA,
    5. Tobias JD

    . Dexmedetomidine as single continuous sedative during noninvasive ventilation: typical usage, hemodynamic effects, and withdrawal. Pediatr Crit Care Med 2018;19(4):287-297.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Whalen LD,
    2. Di Gennaro JL,
    3. Irby GA,
    4. Yanay O,
    5. Zimmerman JJ

    . Long-term dexmedetomidine use and safety profile among critically ill children and neonates. Pediatr Crit Care Med 2014;15(8):706-714.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Franck LS,
    2. Scoppettuolo LA,
    3. Wypij D,
    4. Curley MAQ

    . Validity and generalizability of the withdrawal assessment tool-1 (WAT-1) for monitoring iatrogenic withdrawal syndrome in pediatric patients. Pain 2012;153(1):142-148.

    OpenUrlCrossRefPubMed